Endoscope illumination system for a fluorescent agent
By separating the excitation light and fluorescence spectrum using a dual-light source illumination device and an optical filter, the conflict between imaging and treatment in NIR-PIT is resolved, enabling efficient simultaneous fluorescence imaging and treatment, and optimizing the operational efficiency of the endoscopic system.
Patent Information
- Application Number
- CN202180046248.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-07-03
- Filing Date
- 2021-06-24
- Publication Date
- 2026-07-14
- Estimated Expiration
- 2041-06-24
AI Technical Summary
In existing technologies, near-infrared photoelectroimmunotherapy (NIR-PIT) suffers from a conflict between the excitation light and fluorescence spectra when using IR700 fluorescence imaging and treatment, making it difficult to achieve efficient imaging and treatment simultaneously.
A dual-light source illumination device is used, with one light source having a peak wavelength of 660-699nm for fluorescence imaging and the other light source having a peak wavelength of 689-705nm for treatment. The excitation light and fluorescence spectrum are separated by a dichroic mirror and an optical filter, and the light source switching is independently controlled to optimize imaging and treatment effects.
This enables simultaneous high-efficiency fluorescence imaging and treatment within an endoscopic system, reducing surgical time, alleviating the burden on patients and medical personnel, and improving treatment efficiency.